HEADER OXIDOREDUCTASE 15-FEB-18 6FQY TITLE PLASMODIUM FALCIPARUM 6-PHOSPHOGLUCONATE DEHYDROGENASE IN ITS APO TITLE 2 FORM, IN COMPLEX WITH ITS COFACTOR NADP+ AND IN COMPLEX WITH ITS TITLE 3 SUBSTRATE 6-PHOSPHOGLUCONATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: 6-PHOSPHOGLUCONATE DEHYDROGENASE, DECARBOXYLATING; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.1.1.44; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM 3D7; SOURCE 3 ORGANISM_TAXID: 36329; SOURCE 4 GENE: PF14_0520, PF3D7_1454700; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI M15; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 1007065 KEYWDS PLASMODIUM, COMPLEX, SUBSTRATE, REDOXREGULATION, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR K.FRITZ-WOLF,K.HAEUSSLER,M.REICHMANN,S.RAHLFS,K.BECKER REVDAT 3 17-JAN-24 6FQY 1 REMARK REVDAT 2 24-OCT-18 6FQY 1 SOURCE JRNL REVDAT 1 22-AUG-18 6FQY 0 JRNL AUTH K.HAEUSSLER,K.FRITZ-WOLF,M.REICHMANN,S.RAHLFS,K.BECKER JRNL TITL CHARACTERIZATION OF PLASMODIUM FALCIPARUM 6-PHOSPHOGLUCONATE JRNL TITL 2 DEHYDROGENASE AS AN ANTIMALARIAL DRUG TARGET. JRNL REF J. MOL. BIOL. V. 430 4049 2018 JRNL REFN ESSN 1089-8638 JRNL PMID 30098336 JRNL DOI 10.1016/J.JMB.2018.07.030 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (DEV_2645: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.60 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 23619 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.940 REMARK 3 FREE R VALUE TEST SET COUNT : 1876 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.9105 - 6.8131 1.00 1807 154 0.1998 0.2260 REMARK 3 2 6.8131 - 5.4102 1.00 1715 145 0.2606 0.3148 REMARK 3 3 5.4102 - 4.7270 1.00 1669 146 0.2115 0.2444 REMARK 3 4 4.7270 - 4.2951 1.00 1690 144 0.1927 0.2428 REMARK 3 5 4.2951 - 3.9874 1.00 1665 141 0.2004 0.3047 REMARK 3 6 3.9874 - 3.7524 1.00 1671 143 0.2127 0.3040 REMARK 3 7 3.7524 - 3.5645 1.00 1645 149 0.2332 0.3050 REMARK 3 8 3.5645 - 3.4094 1.00 1651 143 0.2521 0.3290 REMARK 3 9 3.4094 - 3.2782 1.00 1667 146 0.2762 0.3659 REMARK 3 10 3.2782 - 3.1651 1.00 1626 143 0.2993 0.3939 REMARK 3 11 3.1651 - 3.0662 1.00 1657 143 0.3223 0.4068 REMARK 3 12 3.0662 - 2.9785 1.00 1633 145 0.2963 0.3519 REMARK 3 13 2.9785 - 2.9001 1.00 1647 134 0.2768 0.3366 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.440 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.410 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 74.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 7635 REMARK 3 ANGLE : 0.994 10310 REMARK 3 CHIRALITY : 0.056 1135 REMARK 3 PLANARITY : 0.004 1309 REMARK 3 DIHEDRAL : 5.221 4596 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FQY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-FEB-18. REMARK 100 THE DEPOSITION ID IS D_1200008792. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUL-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9538 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS 2017 REMARK 200 DATA SCALING SOFTWARE : XSCALE 2017 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23632 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 43.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.17000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX DEV_2645: ??? REMARK 200 STARTING MODEL: 6FQZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% MME550 AND 0.1 M HEPES (4.6), PH REMARK 280 4.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 121.16667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 60.58333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 60.58333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 121.16667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 35570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -68.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN B 14 OG1 THR B 40 1.71 REMARK 500 OE2 GLU A 394 O HOH A 601 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLU A 387 NH2 ARG A 460 5675 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 6 CB - CG - CD2 ANGL. DEV. = -18.2 DEGREES REMARK 500 ARG B 369 CA - CB - CG ANGL. DEV. = 18.6 DEGREES REMARK 500 ARG B 369 CB - CG - CD ANGL. DEV. = -25.7 DEGREES REMARK 500 GLU B 387 CA - CB - CG ANGL. DEV. = 15.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 10 -149.78 -91.37 REMARK 500 LEU A 226 31.40 -98.05 REMARK 500 PHE A 303 72.01 -110.31 REMARK 500 PRO A 439 25.64 -71.96 REMARK 500 THR A 454 160.59 62.39 REMARK 500 ALA B 10 -148.34 62.86 REMARK 500 LEU B 226 31.14 -94.14 REMARK 500 ASN B 227 107.49 -57.36 REMARK 500 PHE B 303 73.20 -106.16 REMARK 500 PRO B 439 23.75 -71.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAP A 501 REMARK 610 NAP B 500 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP B 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6FQZ RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH 6PG REMARK 900 RELATED ID: 6FQX RELATED DB: PDB REMARK 900 APO FORM OF THE SAME PROTEIN REMARK 900 RELATED ID: 6FQY RELATED DB: PDB REMARK 900 COMPLEXED WITH NADP+, PARTIALLY VISIBLE DBREF 6FQY A 1 468 UNP Q8IKT2 Q8IKT2_PLAF7 1 468 DBREF 6FQY B 1 468 UNP Q8IKT2 Q8IKT2_PLAF7 1 468 SEQRES 1 A 468 MET CYS ASP ILE GLY LEU ILE GLY LEU ALA VAL MET GLY SEQRES 2 A 468 GLN ASN LEU SER LEU ASN ILE SER SER LYS GLY PHE LYS SEQRES 3 A 468 ILE GLY VAL TYR ASN ARG THR TYR GLU ARG THR GLU GLU SEQRES 4 A 468 THR MET LYS ARG ALA LYS GLU GLU ASN LEU VAL VAL TYR SEQRES 5 A 468 GLY TYR LYS THR VAL GLU GLU LEU ILE ASN ASN LEU LYS SEQRES 6 A 468 LYS PRO ARG LYS VAL ILE LEU LEU ILE LYS ALA GLY PRO SEQRES 7 A 468 ALA VAL ASP GLU ASN ILE SER ASN ILE LEU LYS HIS PHE SEQRES 8 A 468 GLU LYS GLY ASP ILE ILE ILE ASP GLY GLY ASN GLU TRP SEQRES 9 A 468 TYR ILE ASN SER GLU ARG ARG ILE LYS LEU CYS LYS GLU SEQRES 10 A 468 LYS ASP VAL GLU TYR LEU ALA MET GLY VAL SER GLY GLY SEQRES 11 A 468 GLU ALA GLY ALA ARG TYR GLY CYS SER PHE MET PRO GLY SEQRES 12 A 468 GLY SER LYS TYR ALA TYR ASP CYS VAL LYS GLU ILE LEU SEQRES 13 A 468 GLU LYS CYS SER ALA GLN VAL GLY ASN SER PRO CYS VAL SEQRES 14 A 468 THR TYR ILE GLY PRO GLY SER SER GLY ASN TYR VAL LYS SEQRES 15 A 468 MET VAL HIS ASN GLY ILE GLU TYR GLY ASP MET GLN LEU SEQRES 16 A 468 ILE SER GLU SER TYR VAL ILE MET LYS HIS ILE LEU LYS SEQRES 17 A 468 TYR ASP ASN GLN LYS LEU SER GLU VAL PHE ASN LYS TRP SEQRES 18 A 468 ASN GLU GLY ILE LEU ASN SER TYR LEU ILE GLU ILE THR SEQRES 19 A 468 ALA ASN ILE LEU ALA LYS LYS ASP ASP LEU THR ASN ASN SEQRES 20 A 468 TYR LEU VAL ASP MET ILE LEU ASP ILE ALA GLY ALA LYS SEQRES 21 A 468 GLY THR GLY LYS TRP THR MET LEU GLU ALA THR GLU ARG SEQRES 22 A 468 GLY ILE PRO CYS PRO THR MET CYS ALA ALA LEU ASP ALA SEQRES 23 A 468 ARG ASN ILE SER VAL PHE LYS GLU LEU ARG THR LYS ALA SEQRES 24 A 468 GLU SER ASN PHE ASN LYS ASP ASN ILE LEU ILE ASP PRO SEQRES 25 A 468 ASN GLU ASP LEU ASN ASP PHE GLU ASN ASP LEU LEU ASN SEQRES 26 A 468 ALA LEU TYR CYS CYS LYS ILE ILE SER TYR THR GLN GLY SEQRES 27 A 468 LEU PHE LEU LEU LYS GLN VAL SER GLU GLU MET ASN TRP SEQRES 28 A 468 LYS LEU ASN LEU GLY GLU ILE ALA ARG ILE TRP ARG GLY SEQRES 29 A 468 GLY CYS ILE ILE ARG ALA VAL PHE LEU ASP ARG ILE ALA SEQRES 30 A 468 ASN ALA TYR LYS ASN ASN GLU LYS LEU GLU LEU LEU PHE SEQRES 31 A 468 LEU ASP ASN GLU PHE SER ASP ASP ILE LYS ASN LYS LEU SEQRES 32 A 468 PRO SER LEU ARG LYS ILE VAL LEU MET ALA THR LYS TYR SEQRES 33 A 468 SER ILE PRO ILE PRO ALA PHE SER ALA SER LEU ALA TYR SEQRES 34 A 468 PHE GLN MET VAL THR SER GLN ASN LEU PRO LEU ASN LEU SEQRES 35 A 468 VAL GLN ALA GLN ARG ASP TYR PHE GLY SER HIS THR TYR SEQRES 36 A 468 ARG ARG THR ASP ARG GLU GLY ASN TYR HIS THR LEU TRP SEQRES 1 B 468 MET CYS ASP ILE GLY LEU ILE GLY LEU ALA VAL MET GLY SEQRES 2 B 468 GLN ASN LEU SER LEU ASN ILE SER SER LYS GLY PHE LYS SEQRES 3 B 468 ILE GLY VAL TYR ASN ARG THR TYR GLU ARG THR GLU GLU SEQRES 4 B 468 THR MET LYS ARG ALA LYS GLU GLU ASN LEU VAL VAL TYR SEQRES 5 B 468 GLY TYR LYS THR VAL GLU GLU LEU ILE ASN ASN LEU LYS SEQRES 6 B 468 LYS PRO ARG LYS VAL ILE LEU LEU ILE LYS ALA GLY PRO SEQRES 7 B 468 ALA VAL ASP GLU ASN ILE SER ASN ILE LEU LYS HIS PHE SEQRES 8 B 468 GLU LYS GLY ASP ILE ILE ILE ASP GLY GLY ASN GLU TRP SEQRES 9 B 468 TYR ILE ASN SER GLU ARG ARG ILE LYS LEU CYS LYS GLU SEQRES 10 B 468 LYS ASP VAL GLU TYR LEU ALA MET GLY VAL SER GLY GLY SEQRES 11 B 468 GLU ALA GLY ALA ARG TYR GLY CYS SER PHE MET PRO GLY SEQRES 12 B 468 GLY SER LYS TYR ALA TYR ASP CYS VAL LYS GLU ILE LEU SEQRES 13 B 468 GLU LYS CYS SER ALA GLN VAL GLY ASN SER PRO CYS VAL SEQRES 14 B 468 THR TYR ILE GLY PRO GLY SER SER GLY ASN TYR VAL LYS SEQRES 15 B 468 MET VAL HIS ASN GLY ILE GLU TYR GLY ASP MET GLN LEU SEQRES 16 B 468 ILE SER GLU SER TYR VAL ILE MET LYS HIS ILE LEU LYS SEQRES 17 B 468 TYR ASP ASN GLN LYS LEU SER GLU VAL PHE ASN LYS TRP SEQRES 18 B 468 ASN GLU GLY ILE LEU ASN SER TYR LEU ILE GLU ILE THR SEQRES 19 B 468 ALA ASN ILE LEU ALA LYS LYS ASP ASP LEU THR ASN ASN SEQRES 20 B 468 TYR LEU VAL ASP MET ILE LEU ASP ILE ALA GLY ALA LYS SEQRES 21 B 468 GLY THR GLY LYS TRP THR MET LEU GLU ALA THR GLU ARG SEQRES 22 B 468 GLY ILE PRO CYS PRO THR MET CYS ALA ALA LEU ASP ALA SEQRES 23 B 468 ARG ASN ILE SER VAL PHE LYS GLU LEU ARG THR LYS ALA SEQRES 24 B 468 GLU SER ASN PHE ASN LYS ASP ASN ILE LEU ILE ASP PRO SEQRES 25 B 468 ASN GLU ASP LEU ASN ASP PHE GLU ASN ASP LEU LEU ASN SEQRES 26 B 468 ALA LEU TYR CYS CYS LYS ILE ILE SER TYR THR GLN GLY SEQRES 27 B 468 LEU PHE LEU LEU LYS GLN VAL SER GLU GLU MET ASN TRP SEQRES 28 B 468 LYS LEU ASN LEU GLY GLU ILE ALA ARG ILE TRP ARG GLY SEQRES 29 B 468 GLY CYS ILE ILE ARG ALA VAL PHE LEU ASP ARG ILE ALA SEQRES 30 B 468 ASN ALA TYR LYS ASN ASN GLU LYS LEU GLU LEU LEU PHE SEQRES 31 B 468 LEU ASP ASN GLU PHE SER ASP ASP ILE LYS ASN LYS LEU SEQRES 32 B 468 PRO SER LEU ARG LYS ILE VAL LEU MET ALA THR LYS TYR SEQRES 33 B 468 SER ILE PRO ILE PRO ALA PHE SER ALA SER LEU ALA TYR SEQRES 34 B 468 PHE GLN MET VAL THR SER GLN ASN LEU PRO LEU ASN LEU SEQRES 35 B 468 VAL GLN ALA GLN ARG ASP TYR PHE GLY SER HIS THR TYR SEQRES 36 B 468 ARG ARG THR ASP ARG GLU GLY ASN TYR HIS THR LEU TRP HET NAP A 501 31 HET EDO A 502 4 HET EDO A 503 4 HET NAP B 500 31 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM EDO 1,2-ETHANEDIOL HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 EDO 2(C2 H6 O2) FORMUL 7 HOH *32(H2 O) HELIX 1 AA1 MET A 12 LYS A 23 1 12 HELIX 2 AA2 THR A 33 GLU A 47 1 15 HELIX 3 AA3 THR A 56 ASN A 62 1 7 HELIX 4 AA4 GLY A 77 PHE A 91 1 15 HELIX 5 AA5 TRP A 104 GLU A 117 1 14 HELIX 6 AA6 GLY A 129 GLY A 137 1 9 HELIX 7 AA7 SER A 145 SER A 160 1 16 HELIX 8 AA8 SER A 176 ILE A 206 1 31 HELIX 9 AA9 ASP A 210 ASN A 222 1 13 HELIX 10 AB1 SER A 228 LYS A 240 1 13 HELIX 11 AB2 TYR A 248 ILE A 253 5 6 HELIX 12 AB3 GLY A 261 GLY A 274 1 14 HELIX 13 AB4 CYS A 277 PHE A 292 1 16 HELIX 14 AB5 PHE A 292 PHE A 303 1 12 HELIX 15 AB6 ASP A 318 MET A 349 1 32 HELIX 16 AB7 ASN A 354 TRP A 362 1 9 HELIX 17 AB8 VAL A 371 ASN A 383 1 13 HELIX 18 AB9 LEU A 388 LEU A 391 5 4 HELIX 19 AC1 ASP A 392 TYR A 416 1 25 HELIX 20 AC2 ILE A 420 THR A 434 1 15 HELIX 21 AC3 PRO A 439 SER A 452 1 14 HELIX 22 AC4 VAL B 11 LYS B 23 1 13 HELIX 23 AC5 THR B 33 GLU B 47 1 15 HELIX 24 AC6 THR B 56 ASN B 62 1 7 HELIX 25 AC7 GLY B 77 PHE B 91 1 15 HELIX 26 AC8 TRP B 104 GLU B 117 1 14 HELIX 27 AC9 GLY B 129 GLY B 137 1 9 HELIX 28 AD1 SER B 145 SER B 160 1 16 HELIX 29 AD2 SER B 176 ILE B 206 1 31 HELIX 30 AD3 ASP B 210 ASN B 222 1 13 HELIX 31 AD4 SER B 228 LYS B 240 1 13 HELIX 32 AD5 TYR B 248 ILE B 253 5 6 HELIX 33 AD6 GLY B 261 GLY B 274 1 14 HELIX 34 AD7 CYS B 277 PHE B 292 1 16 HELIX 35 AD8 PHE B 292 PHE B 303 1 12 HELIX 36 AD9 ASP B 318 MET B 349 1 32 HELIX 37 AE1 ASN B 354 TRP B 362 1 9 HELIX 38 AE2 VAL B 371 ASN B 383 1 13 HELIX 39 AE3 LEU B 388 LEU B 391 5 4 HELIX 40 AE4 ASP B 392 TYR B 416 1 25 HELIX 41 AE5 ILE B 420 THR B 434 1 15 HELIX 42 AE6 LEU B 440 GLY B 451 1 12 SHEET 1 AA1 7 TYR A 52 GLY A 53 0 SHEET 2 AA1 7 ILE A 27 TYR A 30 1 N ILE A 27 O TYR A 52 SHEET 3 AA1 7 ILE A 4 ILE A 7 1 N ILE A 4 O GLY A 28 SHEET 4 AA1 7 LYS A 69 LEU A 72 1 O ILE A 71 N ILE A 7 SHEET 5 AA1 7 ILE A 96 ASP A 99 1 O ILE A 98 N LEU A 72 SHEET 6 AA1 7 GLU A 121 SER A 128 1 O LEU A 123 N ILE A 97 SHEET 7 AA1 7 SER A 139 GLY A 144 -1 O SER A 139 N SER A 128 SHEET 1 AA2 2 GLN A 162 VAL A 163 0 SHEET 2 AA2 2 SER A 166 PRO A 167 -1 O SER A 166 N VAL A 163 SHEET 1 AA3 2 TYR A 455 ARG A 456 0 SHEET 2 AA3 2 ASN A 463 TYR A 464 -1 O TYR A 464 N TYR A 455 SHEET 1 AA4 7 TYR B 52 GLY B 53 0 SHEET 2 AA4 7 ILE B 27 VAL B 29 1 N ILE B 27 O TYR B 52 SHEET 3 AA4 7 ILE B 4 GLY B 8 1 N ILE B 4 O GLY B 28 SHEET 4 AA4 7 LYS B 69 LEU B 72 1 O ILE B 71 N ILE B 7 SHEET 5 AA4 7 ILE B 96 ASP B 99 1 O ILE B 96 N VAL B 70 SHEET 6 AA4 7 GLU B 121 SER B 128 1 O LEU B 123 N ILE B 97 SHEET 7 AA4 7 SER B 139 GLY B 144 -1 O GLY B 143 N ALA B 124 SHEET 1 AA5 2 GLN B 162 VAL B 163 0 SHEET 2 AA5 2 SER B 166 PRO B 167 -1 O SER B 166 N VAL B 163 SSBOND 1 CYS A 281 CYS B 281 1555 1555 2.03 CISPEP 1 LYS A 66 PRO A 67 0 -2.13 CISPEP 2 LYS B 66 PRO B 67 0 -4.78 SITE 1 AC1 7 ALA A 10 ASN A 31 ARG A 32 THR A 33 SITE 2 AC1 7 ARG A 36 LYS A 75 ALA A 79 SITE 1 AC2 5 ASN A 102 SER A 128 GLY A 129 LYS A 182 SITE 2 AC2 5 ILE A 367 SITE 1 AC3 6 ASP A 192 LEU A 226 SER A 228 LEU A 230 SITE 2 AC3 6 ILE A 231 LYS A 331 SITE 1 AC4 8 ALA B 10 VAL B 11 ASN B 31 ARG B 32 SITE 2 AC4 8 THR B 33 ARG B 36 LYS B 75 ALA B 79 CRYST1 99.320 99.320 181.750 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010068 0.005813 0.000000 0.00000 SCALE2 0.000000 0.011626 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005502 0.00000